P95– Guideline implementation for patients with non-small cell lung carcinoma in the Netherlands

PRIMARY TRACK

Guideline implementation

SECONDARY TRACK

Performance measures/indicators/quality incentives and guidelines

BACKGROUND (INTRODUCTION)

In the Netherlands, the ACCC facilitates and coordinates the development and implementation of evidence-based national guidelines on diagnosis and treatment of non-small cell lung carcinoma (NSCLC) (www.oncoline.nl).

PURPOSE

Implementation of the guideline NSCLC and as a result improved quality of care.

LEARNING OBJECTIVES (TRAINING GOALS)

1

Give insight into the level of guideline compliance and/or implementation after development.

METHODS

A national expert team formulated indicators based on the actual national guideline of NSCLC to get information on the organization and the accessibility of care and some professional issues. A web-based registration system was built in which the teams themselves could register data of all their NSCLC patients. The project started in October 2008 and will be closed in May 2010.

RESULTS

In this project, 45 of 100 Dutch hospital teams participated. Currently, more than 2700 NSCLC patients are registered. The results over the total project period give insight into the organization and the accessibility of care, like waiting times. Participation of professionals in a multidisciplinary meeting is registered, as well as the presence of psychosocial care, involvement of an oncology nurse, and communication to the general practitioner.

DISCUSSION (CONCLUSION)

The preliminary results after one year are promising. Improvement on many of the indicators, like the overall diagnosis time and the throughput time to treatment, is realized. More patients visit an oncology nurse during the diagnostic process and are asked about their psychosocial needs. The final results will be presented at the conference.

TARGET AUDIENCE(S)

1

Clinical researcher